The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide.

Igor Richter, Tomáš Jirásek, Ivana Havlickova, Radmila Curcikova, Vladimír Šámal, Josef Dvořák, J Bartoš

PubMed · 2019 · 12 citations · 0 references

Abstract

The expression of PD-L1 in prostate cancer cells as potential new predictive biomarker was not confirmed. Further studies are needed to clarify this topic.